Supramycina

Selected form

Doxycycline

Method of action: Antibacterial Broad Spectrum (Bactericidal), Bacteriostatic

Treatment option: Abscess, Lung Abscess, Actinomycosis, Bartonellosis, Lyme Disease, Bronchitis, Bronchopneumonia, Brucellosis, Bubonic Plague, Lymphogranuloma Venereum

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Supramycina

Property	Description
Active ingredient	Doxycycline (hyclate or monohydrate)
Form	Capsules, Tablets, Suspension, Syrup, Powder for injection
Pharmacological class	Tetracycline antibiotic
Mechanism type	Bacteriostatic agent (protein synthesis inhibitor)
Origin	Semisynthetic

What Type of Medicine is Supramycina?

Supramycina is a potent, prescription-only pharmaceutical preparation classified as a semisynthetic tetracycline antibiotic and a broad-spectrum antibacterial agent. Its therapeutic efficacy is centered on the active ingredient, Doxycycline, a single-ingredient product.

Doxycycline is a second-generation compound originating as a synthetic derivative, distinguishing it from earlier tetracyclines. It is clinically recognized for exhibiting superior pharmaceutical characteristics, including enhanced lipid solubility and stability. The medicine's precise pharmacological role is to act as a bacteriostatic agent, meaning its primary function is to inhibit the growth and multiplication of a wide range of harmful bacterial populations, rather than directly killing them. Doxycycline is designated as a tetracycline-class antimicrobial.

Forms, Structure, and General Purpose of Doxycycline

Supramycina is available for administration via multiple routes in diverse dosage forms, including capsules, tablets, suspension, and syrup for oral intake, as well as powder for solution for injection for intravenous use. This wide array of pharmaceutical preparations allows for appropriate use across different clinical contexts.

Its general purpose is to control bacterial challenges in the body through its antimicrobial activity. Crucially, in addition to this primary role, Doxycycline possesses a secondary, distinct anti-inflammatory effect separate from its antimicrobial actions. This unique action helps to mitigate swelling and redness, providing a combined benefit of reducing the microbial load while simultaneously addressing the physical discomfort often associated with various conditions. The high-level composition involves the active compound, typically as Doxycycline hyclate or Doxycycline monohydrate, formulated with necessary pharmaceutical excipients.

Regulatory References

What side effects are possible with Supramycina?

Safety Profile and Serious Warnings

Supramycina is associated with a risk of serious adverse reactions, which has resulted in specific contraindications and required patient cautions. The most significant safety risk is permanent discoloration of the teeth (yellow-gray-brown) and enamel hypoplasia when the drug is used during tooth development (the last half of pregnancy, infancy, and childhood up to age 8). Use in these populations is generally contraindicated.

Serious and clinically significant reactions documented in regulatory sources include:

Intracranial Hypertension (Pseudotumor Cerebri): Symptoms may include severe headache, blurred vision, double vision (diplopia), and potential vision loss. Women of childbearing age who are overweight are at an elevated risk. Concomitant use with isotretinoin is discouraged due to an increased risk.
Clostridioides difficile-Associated Diarrhea (CDAD): This condition can range from mild diarrhea to fatal colitis and must be considered in any patient presenting with diarrhea after antibiotic use.
Photosensitivity: An exaggerated sunburn reaction can occur with exposure to sunlight or ultraviolet light. Patients are advised to minimize exposure and discontinue use at the first sign of skin redness.
Esophageal Injury: Esophageal ulceration or irritation has been reported, requiring patients to take the medication with adequate fluids and avoid lying down for at least 30 minutes after administration.

Adverse Reaction Categories

Common adverse reactions typically involve the gastrointestinal system, such as nausea, vomiting, diarrhea, and abdominal discomfort. Other affected system-organ classes include the skin and subcutaneous tissue (e.g., rash), the nervous system, and the hepatobiliary system (potential for hepatotoxicity).

Restrictions and Monitoring

As with all antibiotics, use may lead to the overgrowth of non-susceptible organisms (superinfection), including fungi like Candida. Discontinuation is required immediately if signs of serious allergic reactions or suspected intracranial hypertension occur. The safety profile requires careful consideration in all patients, especially in pediatric patients, pregnant women, and those with pre-existing conditions that may predispose them to serious adverse effects.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with Supramycina (Doxycycline) is officially documented to result in an increased incidence of side effects, rather than unique toxic manifestations. These presentations often include severe gastrointestinal distress and signs related to Benign Intracranial Hypertension (Pseudotumor Cerebri), such as persistent headache, blurred vision, or diplopia. For infants, bulging fontanels are the documented sign of this condition.

Life-threatening outcomes cited in regulatory documents include the risk of fatal colitis associated with severe Clostridium difficile-associated disease and the potential for permanent vision loss.

Required Emergency Actions and Management

Immediate medical attention must be sought for all suspected cases of overdose. Government guidance states that emergency services must be contacted immediately if symptoms involve collapse, a seizure, trouble breathing, or an inability to be awakened. Discontinuation of the medicine is required if signs of Intracranial Hypertension occur.

Management involves symptomatic and supportive treatment. No specific antidote is known. Regulatory documentation explicitly states that procedures such as hemodialysis or peritoneal dialysis are not of benefit. A specific concern exists for patients with impaired renal function, who face an increased risk of excessive systemic accumulation and potential liver toxicity.

Therapeutic Uses of Supramycina

What Supramycina Treats: Main Uses and Benefits

Supramycina (Doxycycline) is an antibiotic commonly used across several therapeutic domains and is indicated for a broad range of infections as well as specific non-infectious conditions.

This medicine is applied in clinical settings that involve acute or unstable symptom patterns related to susceptible bacteria. It is relevant for easing pronounced symptoms associated with conditions like Rickettsial fevers, certain respiratory or urinary tract infections, and Sexually Transmitted Infections such as Chlamydia and Syphilis. The medication is also used in the management of specific inflammatory skin conditions like moderate to severe Acne vulgaris and Rosacea. The medicine is considered relevant for use in the context of Malaria prevention.

“It is commonly used when short-term symptomatic assistance is needed to address systemic imbalance or localized distress.”

In these contexts, Supramycina supports the patient during difficult episodes by easing distress related to systemic imbalance and managing symptoms that interfere with daily comfort, such as skin lesions and associated redness. This supportive therapeutic benefit supports general well-being during symptomatic phases.

Quick Fact: Relief for Inflammatory Skin Symptoms

The medication is relevant for managing papules, pustules, and associated redness in conditions like acne, applying across domains where additional symptomatic support is needed.

Eligibility and Restrictions for Use

Who Can and Cannot Use Supramycina?

This section describes the officially documented population eligibility and restrictions for Supramycina (Doxycycline), as defined by governmental regulatory documents.

Contraindications and Restrictions

Eligibility Group	Regulatory Status
Tetracycline Hypersensitivity	Contraindicated (Must not use)
Last Half of Pregnancy	Contraindicated (2nd and 3rd trimesters)
Children Under 8 Years	Not Recommended (Conditional use only for severe, life-threatening infections)
Breastfeeding Mothers	Not Recommended (Avoid use)
Hepatic Impairment	Use with Caution (Monitoring required)
Renal Impairment	Use Permitted (No dosage adjustment needed)
Older Adults (Geriatric)	Use Permitted (No special precautions required)

Official Eligibility Summary

Supramycina is contraindicated in patients with a history of hypersensitivity to any drug in the tetracycline class, including Doxycycline. The medicine is also prohibited during the last half of pregnancy due to the risk of fetal teeth discoloration and bone growth inhibition. Regulatory bodies do not recommend use in children under 8 years of age, though restricted use is permitted for certain severe conditions when alternative therapies are unavailable. Use is generally permitted for adults, older adults, and individuals with renal impairment, but requires caution in cases of impaired hepatic function or risk factors for intracranial hypertension.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Supramycina (Doxycycline) documents specific interactions that alter drug exposure or produce pharmacodynamic changes.

Formal restrictions exist where co-administration is strictly avoided. This includes Methoxyflurane due to the documented risk of fatal renal toxicity, and Oral Retinoids (such as Isotretinoin) due to an increased risk of intracranial hypertension. Co-administration with Penicillins is advised to be avoided because the bacteriostatic effect may formally interfere with the bactericidal action.

Several agents are documented to reduce Doxycycline's systemic exposure. The absorption is severely impaired by products containing polyvalent cations, such as Antacids (aluminum, calcium, or magnesium), Iron-containing preparations, Bismuth Subsalicylate, and Proton Pump Inhibitors (PPIs). For these agents, regulatory documents require separation in administration timing to mitigate the non-absorption effect.

Furthermore, anticonvulsant agents like Barbiturates, Carbamazepine, and Phenytoin are documented to decrease the half-life of Doxycycline, accelerating its metabolic clearance. Doxycycline has also been shown to depress plasma prothrombin activity, an officially noted pharmacodynamic effect that requires monitoring and potential dosage adjustment for patients taking Anticoagulant Drugs (e.g., Warfarin).

This regulatory documentation defines the interaction profile primarily through constraints on use and required monitoring, focusing on avoiding additive toxicities and managing changes in drug exposure.

Mechanism of Action

Arresting Bacterial Growth via Ribosomal Blockade

Supramycina (Doxycycline) functions as a bacteriostatic agent by directly targeting the bacterial 30S ribosomal subunit. This precise molecular binding action physically obstructs the process of protein synthesis, preventing the bacteria from producing the necessary proteins for growth and multiplication. The resulting arrest of microbial proliferation allows the host's cellular immune system to engage the non-replicating populations.

Modulating Host Tissue-Destructive Pathways

Independent of its antibacterial role, Doxycycline exerts a host-modulatory effect by serving as an inhibitor of specific host enzymes, primarily Matrix Metalloproteinases (MMPs). These MMPs are often over-expressed in inflammatory states and are responsible for the breakdown of structural tissues. By dampening this enzymatic activity, the drug protects components of the extracellular matrix and contributes to limiting inflammation-driven tissue degradation.

Suppressing Pro-Inflammatory Signaling

The drug also participates in the modulation of physiological signaling by downregulating key inflammatory signaling mediators. It interferes with the production of potent pro-inflammatory cytokines (e.g., TNF-alpha) and acts as a scavenger of Reactive Oxygen Species (ROS). This suppression of excessive inflammatory signals reduces the intensity of the cellular and chemical inflammatory response.

Dosage and Administration Information

How to Use Supramycina — Administration Guidelines

This section outlines the administration instructions for Supramycina (Doxycycline). It is not a substitute for healthcare provider advice.

Administration Protocol

Entity	Administration Guideline
Route of Administration	Primarily Oral (capsule, tablet, suspension). Also available for Intravenous (IV) Infusion in hospital settings.
Dosing Schedule	The standard adult regimen often begins with a Loading Dose of 200 mg on Day 1 (typically split into 100 mg every 12 hours), followed by a Maintenance Dose of 100 mg once daily. Doses for severe infections may be 100 mg twice daily throughout the course.
Timing with Meals	The medication can generally be taken with or without food. However, to minimize the potential for esophageal irritation, take with adequate fluid. Specific low-dose formulations may require administration on an empty stomach.
Age-Group Rules	Use in children le 8 years old is generally discouraged. The dosage for children > 8 years and le 45 kg is based on body weight, starting at 4.4 mg/kg on the first day.

Procedural Conditions

For oral formulations, the medication must be swallowed with a full glass of water (100 mL or more) while the patient is in an upright position (sitting or standing). It is critical to remain upright for at least 30 minutes after ingestion to ensure the medicine passes quickly into the stomach, thereby mitigating the risk of esophageal ulceration. Tablets or capsules must be swallowed whole unless the instructions explicitly permit splitting or opening. The duration of the treatment course varies, often lasting 7 to 14 days, but can extend to 60 days for conditions like post-exposure anthrax prophylaxis.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Supramycina

Evidence for studies exploring Acute Bacterial Infections

Research examining Supramycina's evaluation in studies of bacterial infections, such as certain sexually transmitted infections and Rickettsial fevers, has primarily relied on Randomized Controlled Trials (RCTs) and Systematic Reviews. These investigations focused on measuring the rate of pathogen eradication and the resolution of symptoms reported by patients. Studies monitored pathogen eradication rates and reported low rates of detection at follow-up for several target bacteria, including Chlamydia trachomatis. Prophylaxis (preventive) Trials monitored new infections and tracked the incidence rate. Evidence quality varies across studies for certain situations, and data for certain high-risk populations remain limited.

Evidence for studies exploring Inflammatory Skin Conditions

The research base for Supramycina's evaluation in conditions like Acne Vulgaris and Rosacea is distinct. This research consists primarily of placebo-controlled RCTs and Network Meta-Analyses. These studies measured the mean change in inflammatory lesion counts and tracked changes in the Investigator’s Global Assessment (IGA) score. Studies tracked changes in the average count of inflammatory lesions over the measured period relative to the initial baseline count, and described patterns of change in global assessment scores. What remains uncertain is the duration of the observed effect and long-term outcomes, as follow-up durations were typically limited to 12 to 16 weeks.

What is Still Uncertain About Supramycina

Data are still emerging regarding the evaluation of certain new preventive regimens, and certainty remains low. A significant focus of ongoing research involves the study of the emergence of resistance in bacterial populations; the certainty remains low regarding the full ecological impact. Findings were mixed or inconsistent across certain comparative studies, suggesting that the research provides context but not absolute or universal predictions.

Key Studies & References

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends in San Francisco (Population-level interrupted time series analysis)

Frequently Asked Questions (FAQ)

Common questions about Supramycina (FAQ)

Q: What is Supramycina used for?

Supramycina is an antibiotic medication used to treat a wide range of bacterial infections. It works by stopping the growth of certain types of bacteria.

Q: How should I take Supramycina?

The way you take Supramycina depends on the form prescribed by your healthcare provider. It is available in different formulations, such as tablets, capsules, and liquid suspension. Always follow the specific instructions provided by your doctor or pharmacist exactly. Generally, it is taken orally, often with a full glass of water.

Q: What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. Consult your healthcare provider if you are unsure.

Q: What are the common side effects of Supramycina?

Common side effects may include nausea, vomiting, diarrhea, and stomach discomfort. These effects are usually mild and often go away as your body adjusts to the medication. If these or any other side effects persist or worsen, you should contact your doctor.

Q: Can I drink alcohol while taking Supramycina?

It is generally recommended to avoid or limit alcohol consumption while taking antibiotics, including Supramycina. Alcohol may increase the risk of side effects like nausea or dizziness and could potentially interfere with the effectiveness of the medication. Discuss this with your healthcare provider.

Q: How long will I need to take Supramycina?

The length of your treatment course will be determined by your doctor based on the type and severity of the infection. It is very important to finish the full course of the antibiotic, even if your symptoms begin to improve sooner. Stopping early can lead to the infection coming back or the development of antibiotic resistance.

Q: Can Supramycina interact with other medications?

Supramycina may interact with several other medications, including certain blood thinners, antacids, and mineral supplements. Inform your healthcare provider and pharmacist about all prescription, over-the-counter, and herbal products you are currently taking to avoid potential drug interactions.

Q: Is Supramycina safe during pregnancy or breastfeeding?

If you are pregnant, planning to become pregnant, or breastfeeding, you should consult your healthcare provider before taking Supramycina. The potential risks and benefits must be carefully evaluated to ensure the best outcome for both mother and child.

How should Supramycina be stored and disposed of?

How to Store and Dispose of Supramycina?

The official storage requirements for Supramycina (Doxycycline) are designed to maintain its stability, as documented in regulatory guidelines.

Storage and Handling Requirements

Condition	Requirement
Temperature	Store at controlled room temperature, typically 20 C to 25 C.
Protection	Keep away from excess heat, excess moisture, and light.
Container	Must be kept in the tightly closed original container.
Stability	Any oral suspension must be discarded after 14 days of preparation.
Child Safety	Keep out of the sight and reach of children and pets.

Official Disposal Protocol

Unused or expired Supramycina should be disposed of via an official drug take-back program or by mixing it with an undesirable substance (such as dirt or coffee grounds) and placing it in a sealed container for household trash. The drug is not on the list of medicines recommended for flushing down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.